Goldman Sachs to acquire Norgine

Goldman Sachs is acquiring a majority stake in Norgine, a European specialty pharmaceutical firm.

27 May 2022•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles